Ingredion Incorporated
Ingredion Announces Conditional Sale of Equity in Rafhan Maize
Ingredion Announces Conditional Sale of Equity in Rafhan Maize
WESTCHESTER, Ill., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced that it has signed a conditional agreement to sell a 51% ownership interest in Rafhan Maize to Nishat Hotels and Properties Ltd., located in Lahore, Pakistan. Ingredion will retain a 20% ownership interest in Rafhan Maize. The sale is conditional pending the arrangement of international financing.
The transaction is expected to close in the first half of 2026, subject to regulatory approvals and satisfaction of other customary closing conditions.
About Ingredion
Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in nearly 120 countries. With 2024 annual net sales of approximately $7.4 billion, the Company turns grains, fruits, vegetables, and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion Idea Labs® innovation centers located around the world and more than 11,000 employees, the Company cocreates with customers and fulfills its purpose of bringing the potential of people, nature, and technology together to make life better. Visit ingredion.com for more information and the latest Company news.
CONTACTS:
Investors: Noah Weiss, 773-896-5242
Media: Rick Wion, 708-209-6323
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG29.9.2025 14:15:00 CEST | Press release
Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US
Cosmos Health Inc.29.9.2025 14:00:07 CEST | Press release
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
DLR Kredit A/S29.9.2025 13:51:03 CEST | Pressemeddelelse
Fastsættelse af kuponrenter (Senior, Non-Preferred Note)
Novartis Pharma AG29.9.2025 13:44:34 CEST | Press release
Novartis announces commencement of tender offer to acquire Tourmaline Bio
Djurslands Bank A/S29.9.2025 13:42:07 CEST | Pressemeddelelse
Aktietilbagekøb i Djurslands Bank – transaktioner i uge 39
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom